USA Financial Formulas’s Carlisle Companies CSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$363 Hold
1
﹤0.01% 403
2026
Q1
$334 Hold
1
﹤0.01% 424
2025
Q4
$320 Buy
+1
New +$324 ﹤0.01% 414
2024
Q4
Sell
-630
Closed -$283K 309
2024
Q3
$283K Sell
630
-116
-16% -$48K 0.04% 122
2024
Q2
$302K Sell
746
-57
-7% -$23K 0.05% 120
2024
Q1
$315K Buy
+803
New +$272K 0.05% 144
2023
Q4
Sell
-2
Closed -$519 386
2023
Q3
$519 Hold
2
﹤0.01% 442
2023
Q2
$513 Hold
2
﹤0.01% 427
2023
Q1
$452 Buy
+2
New +$486 ﹤0.01% 374
2022
Q3
$174K Buy
621
+619
+30,950% +$177K 0.27% 60
2022
Q2
$0 Hold
2
﹤0.01% 354
2022
Q1
$0 Sell
2
-1,697
-100% -$398K ﹤0.01% 377
2021
Q4
$422K Buy
+1,699
New +$390K 0.36% 72
2019
Q4
Sell
-7
Closed -$1K 242
2019
Q3
$1K Buy
+7
New +$983 ﹤0.01% 194

Other funds holding CSL

USA Financial Formulas's CSL Position: Q2 2026 in Review

USA Financial Formulas held its Carlisle Companies (CSL) position steady in Q2 2026 at 1 share worth $363. The position accounts for ﹤0.01% of the portfolio, ranked #403.

USA Financial Formulas first reported a position in CSL in Q3 2019 and has held it in 14 quarters since. The position peaked at $422K in Q4 2021. 792 funds tracked by Wall St. Rank hold CSL as of Q2 2026.

  • USA Financial Formulas held 1 share of Carlisle Companies worth $363 as of Q2 2026.
  • USA Financial Formulas left its Carlisle Companies share count unchanged in Q2 2026.
  • Carlisle Companies made up ﹤0.01% of USA Financial Formulas's portfolio in Q2 2026, its #403 holding.
  • USA Financial Formulas first reported a position in Carlisle Companies in Q3 2019 and has held it in 14 quarters since.
  • USA Financial Formulas's Carlisle Companies position peaked at $422K in Q4 2021.
  • 792 funds tracked by Wall St. Rank held Carlisle Companies as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.